Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa

This publication has 166 references indexed in Scilit:

• Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000)
  Diagnostic Microbiology and Infectious Disease, 2002
• Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
  Nature, 2002
• Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): More alike than different!
  Diagnostic Microbiology and Infectious Disease, 2001
• Hospital Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-1, a Novel Transferable Metallo- -Lactamase
  Clinical Infectious Diseases, 2000
• Antimicrobial Resistance in European Isolates of Pseudomonas aeruginosa
  European Journal of Clinical Microbiology & Infectious Diseases, 2000
• Fever in Immunocompromised Patients
  New England Journal of Medicine, 1999
• Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with Granulocytopenia
  New England Journal of Medicine, 1987
• A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
  New England Journal of Medicine, 1986
• Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds
  The Journal of Pediatrics, 1985
• Pseudomonas aeruginosaExotoxin A
  New England Journal of Medicine, 1980